MRTX
Mirati Therapeutics, Inc. Common Stock
MRTX
MRTX
Delisted
MRTX was delisted on the 22nd of January, 2024.
81 hedge funds and large institutions have $757M invested in Mirati Therapeutics, Inc. Common Stock in 2018 Q1 according to their latest regulatory filings, with 32 funds opening new positions, 22 increasing their positions, 19 reducing their positions, and 13 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
81
Holders Change
+18
Holders Change %
+28.57%
% of All Funds
1.86%
Holding in Top 10
5
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-16.67%
% of All Funds
0.11%
New
32
Increased
22
Reduced
19
Closed
13
Calls
$1.31M
Puts
$1.62M
Net Calls
-$308K
Net Calls Change
-$2.24M
Top Buyers
1 |
![]()
Fidelity Investments
Boston,
Massachusetts
|
+$36.4M |
2 |
CAM
Cormorant Asset Management
Boston,
Massachusetts
|
+$21.1M |
3 |
Millennium Management
New York
|
+$11.7M |
4 |
Point72 Asset Management
Stamford,
Connecticut
|
+$10M |
5 |
PC
PointState Capital
New York
|
+$9.16M |
Top Sellers
1 |
BC
Broadfin Capital
New York
|
-$30.8M |
2 |
GTC
Ghost Tree Capital
New York
|
-$10.4M |
3 |
PI
Putnam Investments
Boston,
Massachusetts
|
-$7.55M |
4 |
D.E. Shaw & Co
New York
|
-$5.97M |
5 |
DM
Deerfield Management
New York
|
-$5.46M |